Abstract
Generalized epilepsies are a large group of epilepsies with different clinical aspects and prognosis. Many antiepileptic drugs are available for the treatment of these seizures. This paper reviews the evidence relating to the treatment of this group of epilepsies. Historically, the great majority of patients have been treated with “old” anticonvulsant drugs. Over recent years, there has been a marked improvement in the pharmacological armamentarium of physicians. Today, “new” antiepileptic drugs, such as lamotrigine, levetiracetam, topiramate and zonisamide are useful tools in the treatment of pharmacoresistant epilepsies.
Keywords: Epileptic patients, old antiepileptics, new antiepileptics, epilepsy
Current Clinical Pharmacology
Title: Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies
Volume: 2 Issue: 3
Author(s): Alberto Verrotti, Rita Greco, Raffaella Giannuzzi, Francesco Chiarelli and Giuseppe Latini
Affiliation:
Keywords: Epileptic patients, old antiepileptics, new antiepileptics, epilepsy
Abstract: Generalized epilepsies are a large group of epilepsies with different clinical aspects and prognosis. Many antiepileptic drugs are available for the treatment of these seizures. This paper reviews the evidence relating to the treatment of this group of epilepsies. Historically, the great majority of patients have been treated with “old” anticonvulsant drugs. Over recent years, there has been a marked improvement in the pharmacological armamentarium of physicians. Today, “new” antiepileptic drugs, such as lamotrigine, levetiracetam, topiramate and zonisamide are useful tools in the treatment of pharmacoresistant epilepsies.
Export Options
About this article
Cite this article as:
Verrotti Alberto, Greco Rita, Giannuzzi Raffaella, Chiarelli Francesco and Latini Giuseppe, Old and New Antiepileptic Drugs for the Treatment of Idiopathic Generalized Epilepsies, Current Clinical Pharmacology 2007; 2 (3) . https://dx.doi.org/10.2174/157488407781668794
DOI https://dx.doi.org/10.2174/157488407781668794 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
Physiological Effect and Therapeutic Application of Alpha Lipoic Acid
Current Medicinal Chemistry Mobilization and Redistribution of Default Mode Network from Resting State to Task State in Amnestic Mild Cognitive Impairment
Current Alzheimer Research Astrocyte`s RAGE: More Than Just a Question of Mood
Central Nervous System Agents in Medicinal Chemistry Rivastigmine for Refractory REM Behavior Disorder in Mild Cognitive Impairment
Current Alzheimer Research The Biology of the RNA Binding Protein Guanine-Rich Sequence Binding Factor 1
Current Protein & Peptide Science In-vitro Antioxidant activity of ‘Aswathy Chooranam’- a Siddha Drug
Current Traditional Medicine Glutamate Dehydrogenase as a Promising Target for Hyperinsulinism Hyperammonemia Syndrome Therapy
Current Medicinal Chemistry Conotoxins: Structure, Therapeutic Potential and Pharmacological Applications
Current Pharmaceutical Design Neuroprotective and Neurorestorative Effects of Epo and VEGF: Perspectives for New Therapeutic Approaches to Neurological Diseases
Current Pharmaceutical Design Cyclooxygenases in the Central Nervous System: Implications for Treatment of Neurological Disorders
Current Pharmaceutical Design Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Genome-Wide Expression Analysis in Epilepsy: A Synthetic Review
Current Topics in Medicinal Chemistry Potential Phytotherapeutic Approaches for the Treatment of Alzheimer’s Disease: An Overview
Current Traditional Medicine The Long Run: Neuroprotective Effects of Physical Exercise on Adult Neurogenesis from Youth to Old Age
Current Neuropharmacology Mexiletine Metabolites: A Review
Current Medicinal Chemistry Medial Temporal Lobe Volumes in Amnestic Mild Cognitive Impairment and Late-life Depression: Research Synthesis
Current Psychiatry Reviews Therapeutic Potential, Synthesis, Patent Evaluation and SAR Studies of Thieno[3,2-d]pyrimidine Derivatives: Recent Updates
Current Drug Targets Aptiom (Eslicarbazepine Acetate) as a Dual Inhibitor of β-Secretase and Voltage-Gated Sodium Channel: Advancement in Alzheimer's Disease-Epilepsy Linkage via an Enzoinformatics Study
CNS & Neurological Disorders - Drug Targets Fetal Origins of Cardiovascular Disease
Current Cardiology Reviews Transgenic Mice as a Model for Alzheimers Disease
Current Alzheimer Research